Rx Fundamental Growth Fund

U.S. News evaluated 466 Large Growth Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all FolioMetrix funds

See full Large Growth rankings

See more fund rankings

Performance

Trailing Returns Updated 02.28.2014
Year to date 5.9%
1 Year N/A
3 Years (Annualized) N/A
5 Years (Annualized) N/A
10 Years (Annualized) N/A

See more FMFGX performance

Summary

The investment seeks capital appreciation. The fund's investment sub-advisor, Navellier & Associates, Inc. (the "Sub-Advisor"), seeks to achieve the fund's investment objective of capital appreciation by principally investing in stocks believed to have above-average growth potential. The Sub-Advisor uses a proprietary screening system that incorporates quantitative and fundamental analysis in order to construct the fund's portfolio.